Cargando…

Igniting the slow burn of post-COVID conditions

Post-COVID conditions (PCCs) are persistent new patient symptoms occurring after acute COVID-19 infection and are an increasingly appreciated dimension of the COVID-19 pandemic. The factors that cause PCCs are not well understood. In recent work, Gebo et al. identify a connection between acute IL-6...

Descripción completa

Detalles Bibliográficos
Autor principal: Henderson, Jeffrey P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653924/
https://www.ncbi.nlm.nih.gov/pubmed/37750708
http://dx.doi.org/10.1128/mbio.01489-23
_version_ 1785136518820528128
author Henderson, Jeffrey P.
author_facet Henderson, Jeffrey P.
author_sort Henderson, Jeffrey P.
collection PubMed
description Post-COVID conditions (PCCs) are persistent new patient symptoms occurring after acute COVID-19 infection and are an increasingly appreciated dimension of the COVID-19 pandemic. The factors that cause PCCs are not well understood. In recent work, Gebo et al. identify a connection between acute IL-6 levels, early COVID-19 convalescent plasma (CP) administration, and later PCCs in subjects from a randomized controlled trial of acutely ill subjects enrolled in 2020 to 2021 (K. A. Gebo, S. L. Heath, Y. Fukuta, X. Zhu, et al., mBio e00618-23, 2023, https://doi.org/10.1128/mbio.00618-23). These results may be viewed as part of an emerging picture linking the intensity of inflammatory responses during acute infection to later PCCs.
format Online
Article
Text
id pubmed-10653924
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-106539242023-09-26 Igniting the slow burn of post-COVID conditions Henderson, Jeffrey P. mBio Commentary Post-COVID conditions (PCCs) are persistent new patient symptoms occurring after acute COVID-19 infection and are an increasingly appreciated dimension of the COVID-19 pandemic. The factors that cause PCCs are not well understood. In recent work, Gebo et al. identify a connection between acute IL-6 levels, early COVID-19 convalescent plasma (CP) administration, and later PCCs in subjects from a randomized controlled trial of acutely ill subjects enrolled in 2020 to 2021 (K. A. Gebo, S. L. Heath, Y. Fukuta, X. Zhu, et al., mBio e00618-23, 2023, https://doi.org/10.1128/mbio.00618-23). These results may be viewed as part of an emerging picture linking the intensity of inflammatory responses during acute infection to later PCCs. American Society for Microbiology 2023-09-26 /pmc/articles/PMC10653924/ /pubmed/37750708 http://dx.doi.org/10.1128/mbio.01489-23 Text en Copyright © 2023 Henderson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Henderson, Jeffrey P.
Igniting the slow burn of post-COVID conditions
title Igniting the slow burn of post-COVID conditions
title_full Igniting the slow burn of post-COVID conditions
title_fullStr Igniting the slow burn of post-COVID conditions
title_full_unstemmed Igniting the slow burn of post-COVID conditions
title_short Igniting the slow burn of post-COVID conditions
title_sort igniting the slow burn of post-covid conditions
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653924/
https://www.ncbi.nlm.nih.gov/pubmed/37750708
http://dx.doi.org/10.1128/mbio.01489-23
work_keys_str_mv AT hendersonjeffreyp ignitingtheslowburnofpostcovidconditions